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ABSTRACT

EPIGENETIC REGULATION DURING THE DIFFERENTIATION OF EMBRYONIC STEM
CELLS INTO CARDIOMYOCYTES
by
Nan Yang
University of New Hampshire

Heart disease is the leading cause of death in the United States, constituting a quarter of
total deaths every year. One reason behind the high mortality of heart disease is the limited
regenerative capacity of cardiomyocytes (CMs), which carry out the contractile function for the
heart. Lineage-specific differentiation of pluripotent stem cells into CMs provides a promising
therapeutic strategy, warranting in-depth research for the mechanistic understanding of this
sophisticated process to achieve homogenous production of cardiomyocytes with high purity and
large quantity. Three-dimensional culture systems, such as microporous hydrogel, have been
demonstrated to promote CM differentiation but little is known about the underlying mechanism.
This project focuses on histone proteins, which are important components of nucleosome, and their
modifications regulate a multitude of cellular processes include differentiation. Using quantitative
mass spectrometric analysis, changes in histone modification landscape during embryonic stem
cell (ESC) differentiation were characterized and a substantial upregulation in histone H4 Lys16
acetylation (H4 K16ac) was detected in cells enriched in cardiomyocytes. Interestingly, H4 K16ac
was also significantly increased in cells cultured in hydrogels, suggesting that hydrogel culture
potentially primes the epigenetic state of ESCs for cardiomyocyte differentiation. To better
viii

understand signaling pathways involved in mechanosensing of hydrogel environment, we
quantitatively compared the Phosphoproteomics of ESCs cultured in hydrogel 3D environment
and on 2D tissue culture plates. Together, our results provide novel molecular insights on how
mechanosensing signaling regulates epigenome transformation to promote lineage specification.

ix

CHAPTER 1
INTRODUCTION

I.

Cardiomyocytes Differentiation

Coronary heart disease is the leading cause of death in the United States, constituting a quarter
of total deaths every year.1 Ischemic heart disease (IHD) is the largest portion inside heart diseases,
which is caused by lacking blood and oxygen to myocardium.2 Cardiac muscle tissue is mainly
made up with cardiomyocytes (CMs), which carry out the contractile function for the heart. The
limited regenerative capacity of heart leads to a permanent reduction of CMs in IHD, contributing
to the high mortality of heart disease. Many strategies have been investigated to improve the heart
function over the past 20 years, which can be categorized as noncell-based and cell-based
therapies3. Noncell-based therapies aim at promoting heart repair by using growth factors,
microRNAs, and other secretory factors, but are limited by little regenerative capacity of heart and
inefficient delivery of therapeutic factors.3 Cell-based therapies utilize functional cardiomyocytes
that are differentiated from pluripotent stem cells (PSCs) to replenish contractile function of an
injured heart. However, cell-based therapies suffer from inconsistencies of engraftment rate and
the possibility of arrhythmia has been the major problem. Enough number of CMs with high pure
and mature characteristics is expected to help to solve these problems. Thus, a mechanistic
understanding of cardiomyocyte differentiation at the molecular level is essential, though remains
elusive.

1

Pluripotent stem cells (PSCs) can provide an attractive source of CMs because of their ability
to self-renew and differentiate into all three germ layers. There are two types of PSCs, embryonic
stem cells (ESCs) and induced pluripotent stem cells (iPSCs). ESCs provide excellent source for
functional CMs because they can proliferate unlimitedly and can differentiate into CMs in vitro.
In addition, it has been shown that transplanted ESCs derived CMs can contract synchronously
with host myocardium in some animal models.4 However, immunoreaction and ethical problem
are major issues that limit ESCs-derived CMs’ application. As an alternate option, iPSCs are
pluripotent stem cells, just like ESCs, that are reprogrammed from somatic cells by overexpressing
four transcription factors: Oct3/4, Sox2, c-Myc, and Klf4.5 It was shown that iPSCs-derived CMs
transplantation improved heart function in short term and it also avoided the immunoreaction and
ethical issues that ESCs have. Further, iPSC-derived CMs are excellent tissue culture models for
high throughput screening of cardiotoxicity in drug development, with the potential to provide
valuable patient-specific information in precision medicine. However, most iPSCs-derived CMs
are immature cardiac progenitors and haven’t shown long-term survival.6 Furthermore, high
product variation and low yield of PSCs-derived CMs are even more notable problems. Current
strategies have been largely limited to manipulating Wnt-signaling by using growth factors and
small molecules. Little is known about the nature and function of histone modifications in this
epigenetic phenomenon. Therefore, it is necessary to characterize epigenetic landscape during the
differentiation of PSCs into CMs.
II.

Hydrogel

There are several methods for deriving CMs from PSCs. After dissociating, ESCs can
aggregate into a spheroid, as known as embryoid bodies (EBs), with three germ layers of
endoderm, mesoderm (from which cardiac cells develop) and ectoderm. Cells in EBs can
2

spontaneously differentiate into multiple cell lineages, including cardiomyocytes. This provided a
convenient method to derive CMs from PSCs. But high variation and low yield were overserved
and motivated further studies for improved protocols.7 Another early strategy was to co-culture
PSCs with END2 cells, which was overserved to having cardiac induction activity.8 It was also
revealed that undefined components in serum contributed to variations in CM differentiation, so
fully defined serum or serum-free media were used in later developed protocols. Multiple signaling
pathways have been found to play a role in cardiac differentiation, including but not limited to:
Wnt, BMP, Nodal/Activin, FGF. Wnt/β-catenin signaling is biphasic in cardiomyocyte
differentiation, with an early Wnt/β-catenin signaling activation to promote mesoderm formation
and a later Wnt/β-catenin signaling inhibition to facilitate cardiomyocyte lineage specification.
Similarly, BMP signaling promotes mesoderm formation over ectoderm and endoderm in early
stages and cardiac specification of mesoderm. Nodal signaling can regulate the formation of
anterior mesoderm and endoderm, which produce some essential factors for cardiac development.
Furthermore, FGFs cooperate with BMP and Nodal to guide the formation of mesoderm.9 Based
on the understanding of the signaling pathways in cardiac development, methods were developed
with serum-free media and the addition of growth factors and small molecules, including
CHIR99021 (Wnt), BMP4 (BMP), Activin A (Nodal/Activin), and VEGF,7 to manipulate
corresponding signaling pathways.
Methods of deriving CMs from PSCs have been developed but approaches to obtain fully
maturation CMs were still necessary to prevent arrhythmia or tachycardia. Strategies to promote
the maturation of CMs include biochemical, physical stimulations, and cardiac tissue engineering
techniques. Biochemical methods include Akt signaling activation, β-adrenergic stimulation
triiodothyronine and so on. For example, both FGF and VEGF can activate Akt signaling, which
3

upregulates CM-specific gene expression and promotes intracellular calcium fluxes. Physical
stimulations include electrical signals, substrate topography and stiffness, mechanical stretching,
and magnetic field. The tissue engineering methods include engineered heart tissue, hydrogels,
adjustment of the microenvironment, and application-oriented approaches like cell patches.10
Hydrogel forms 3D hydrophilic matrix made up of cross-linked polymers, which can be used
as scaffolds to better mimic in vivo environment for cell growth. In addition, physiochemical
properties of hydrogel can be fine-tuned for tissue culture and engineering needs. Culturing human
ESCs-derived CMs in a three-dimensional (3D) hydrogel scaffold could improve CMs
differentiation and maturation. For example, the expression of cTnT, α-MHC, SERCA2, and
CASQ2 was upregulated in the hydrogel, which contributes to contraction function and excitationcontraction coupling. Sarcomere structure was also longer in hydrogel compared to twodimensional fibrin substrate.11 There was also evidence showing that even short-term culturing of
tumor cells in two-dimensional tissue culture plates would significantly later histone proteins, from
proteolytic cleavage of histone N-terminal tails to the abundance of H3K14me1, H3K27me2,
H3K27me3, H3K36me1, and H3K36me2.12 However, little is known about detailed changes in
histone epigenetic states when cultured in 3D hydrogel compared to conventional 2D tissue culture
(TC) plates.
III.

Histone Modifications

Cardiac development is driven by sequentially expressed cardiac transcription factors (TFs).
Some important TFs in the cardiac development gene network are GATA4, TBX5, NKX2-5,
MEF2, and HAND1.13 Together with histone modifications, chromatin-modifying, and
remodeling complexes, these TFs regulate the expression of cardiac genes for the proper function
of myocardium.
4

Chromatin is composed of nucleosomes as structural and functional units, which contains 147
bp of DNA wrapping around an octamer of two copies of each core histone protein, H2A, H2B,
H3, and H4. Histones are highly conserved, basic high abundance chromatin proteins with flexible
N-terminal tails protruding from nucleosome DNA. The histone tails are heavily modified with
acetylation methylation, ubiquitination, and sumoylation on lysine residues, phosphorylation on
serine, threonine, and tyrosine residues. These modifications can affect gene transcription in two
major ways. First, histone modifications can alter DNA-histone interaction to affect the chromatin
structure and accessibility of DNA, therefore control transcription. For example, acetylation of
Lys27 in H3 (H3K27ac) reduces the positive charge of histone proteins, thus weaken the
electrostatic interactions between positively-charged histone proteins and negative-charged DNA
to increase the accessibility of DNA and promote transcription activation.14 Second, histone
modifications can be recognized by regulators to recruit activator or suppressor binding and alter
local chromatin structure. For instance, trimethylation of Lys27 in H3 (H3K27me3) can help the
binding of Polycomb-repressive multiprotein complex 1 (PRC1), which mediates ubiquitination
of H2A and transcription repression.15
Posttranslational modifications on histone proteins are highly dynamic, installed or removed
by chromatin-modifying complexes. Acetylation of lysine residues in histone proteins can be
carried out by histone acetyltransferases (HAT) to neutralize the positive charge of histone protein
and increase the accessibility of DNA and gene expression. It can be erased by histone deacetylases
(HDAC) to restore the compact chromatin and repress gene expression. Similarly, methylation of
histone proteins can be added by histone methyltransferases (HMT) and removed by histone
demethylases (HDM). Therefore, different histone modification levels can be manipulated by
affecting the balance between “writers” (like HAT) and “erasers” (like HDAC). For example,
5

SAHA and FK288 are two FDA-approved HDAC inhibitors for the anticancer filed.16 And these
enzymes are also subjected to posttranslational modifications, for instance, phosphorylation of
HDAC1 is imported for its enzyme activity and complex formation.17
Histone modifications can be interpreted by reader proteins, which contain specific modules,
based on unique histone sequence and modification states. Acetylation of histone proteins can be
recognized by bromodomain of chromatin-associated proteins. For instance, Gcn5P bromodomain
binds to acetylated lysine 16 in H4 (H4K16ac) and then plays a role in transcription activation.
Methylation marks of histone proteins can be binding with the Royal superfamily members and
plant homeodomain (PHD) fingers.18 For example, double chromodomains of chromo helicase
DNA-binding (CHD) proteins, which belong to the Royal superfamily, can recognize the
methylation of lysine 4 in histone H3 and regulate nucleosome assembly and transcription.
Histone modifications can interact not only with reader proteins but also with one or more
subsequent modifications, as known as cross-regulation or cross-talk. The first level of cross-talk
is provided by different types of modifications of lysine and arginine residues in situ, which means
one modification can block subsequent modification. For example, acetylation of lysine 9 in H3
(H3K9ac) is always mutually exclusive with its methylation (H3K9me) while their functions are
always opposite. H3K9ac is associated with transcription activating whereas H3K9me is
associated with transcription repressing. Another type of cross-talk is on the same histone protein,
or in cis. For instance, phosphorylation of serine 10 in H3 (H3S10ph) promotes acetylation of
lysine 14 in H3 (H3K14ac) whereas blocks H3K9me and H3K9ac. This cross-talk controls the
binding of the heterochromatin protein 1 (HP1) to H3, which affects constitutive heterochromatin
formation. The third type of cross-talk is between different histone proteins or even nucleosomes.
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For example, mono-ubiquitination of lysine 123 in H2B is required for methylation of H3K4 and
H3K79 in yeast.19
Histone modifications can affect many cellular processes, including cardiomyocytes
differentiation. H3K27 acetylation plays a role in cardiac lineage development. Lacking H3K27
methyltransferase PCR2 led to defect in cardiac morphology and non-cardiac gene expression.
Loss of H3K27 demethylase KDM6B (H3K27me3) caused low cardiomyocytes proliferation
rate.20 H3K4 mono-methyltransferase SETD7 interacted with methylated H3K36 to facilitate
transcription and control the cardiac differentiationa.21, 22 Abnormal global ubiquitination level in
H2B led to heart defective development.23 DOT1L, H3 lysine 79 methyltransferase in mammals,
is needed for normal mammalian development.24 Therefore, characterizing histone epigenetic
states and identifying histone epigenetic barriers during cardiac differentiation can help to facilitate
the generation of CMs from PSCs for cardiac regeneration purpose.
IV.

Protein Identification and quantitation through Mass Spectrometry

Mass spectrometry (MS) has become one of the most popular techniques for proteomics
research, which uses mass information to determine molecule structure. More complex and deeper
information can be acquired from MS compared to two-dimensional gel electrophoresis or protein
microarrays. MS can be used for identifying proteins, quantifying protein expression,
characterizing protein-protein interactions, identifying and quantifying protein modifications,
which is suitable for the analysis of histone modifications. Electrospray ionization (ESI) and
matrix-assisted laser desorption/ionization (MALDI) are two important ionization techniques
suitable for proteins and peptides. Mass analyzer can separate analyte ions in time or space based
on different m/z (mass/charge) values and detector can register signal intensity (correlating to the
number of ions) at various m/z values. Tandem MS (MS/MS) provides additional key information
7

for the identification of proteins and modifications. Peptide or protein ions can be fragmented on
the peptide backbone through collision-induced dissociation (CID) to generate a series of Nterminal b ions and C-terminal y ions for database search. The accurate mass of a peptide and that
of its fragment b and y ions will be utilized to search against a protein database. Candidate peptides
with a mass error window are scored and ranked based on the match of y and b ions. False
discovery rates of database search are assessed using identical protein and peptide score thresholds
but on a database with a normal database concatenated with randomized/decoy database.
There are two major approaches to analyzing protein using MS, “bottom-up” and “top-down”
approaches. The “bottom-up” approach involves enzymatically digesting proteins into small
peptides which can be used for protein identification. Generally, there are two “bottom-up”
strategies. The first strategy is based on mass measurements for tryptic peptides from proteins,
which is referred to as peptide mass fingerprinting. But peptide mass fingerprinting strategy
requires isolation of a single protein or a simple mixture for successful identification. The second
strategy is based on the mass information of fragments generated by CID of pre-isolated peptides
to identify proteins with a low number of peptides needed.25 The “bottom-up” approach usually
does not recover all tryptic peptides of a given protein thus not very suitable for comprehensive
analysis of various protein isoforms with distant posttranslational modification patterns. However,
it is still widely used because of its high sensitivity and efficiency.26 In the “top-down” approach,
intact protein ions are isolated for mass measurement and gas-phase fragmentation for tandem MS
(MS/MS) analysis. The “top-down” approach can provide complete sequence coverage of
analyzed proteins, including all modifications compared to “bottom-up” approach. But it always
required a large amount of highly purified proteins, thus has low sensitivity. Therefore, in this
project, the “bottom-up” approach was used for the identification and quantitation of histone
8

modifications. Before running into MS, proteins can be digested with a proteolytic enzyme like
trypsin to generate tryptic peptides ending with a basic Lys or Arg residue at the C-terminus. Then
tryptic peptides can be separated through reversed-phase high-performance liquid chromatography
(RP-HPLC) based on their hydrophobicity and introduced into ion source for ionization, followed
by MS analysis to obtain m/z and ion intensity values for each peptide. High abundance peptides
are also selected and go through CID to get MS/MS information. The MS result of protein or
peptide can be handled with bioinformatics software to search with protein/peptide databases and
return match results which usually including protein/peptide sequence, modifications for each
amino acid, and other relevant information.
For quantitation analysis based on MS, there are two major approaches, label-free approach,
and labeling approach. In the label-free approach, each sample is prepared and analyzed by MS
separately and peptide ion intensity or spectral count is measured in individual samples and
compared for comparative quantitation analysis. Technical variations in the label-free quantitation
approach are relatively larger than the labeling approach, largely due to variations introduced by
upstream biochemical sample preparation steps prior to LC-MS analysis. In the labeling approach,
there are four major methods: isotopic coded affinity tag (ICAT), isobaric tags for relative and
absolute quantitation (iTRAQ), stable isotope labeling of amino acids in cell culture (SILAC) and
H218O labeling.27 ICAT uses affinity tags that react with cysteine residues in a protein. Different
samples for quantitation react with different labeling reagents with heavy or light isotopes
(hydrogen or deuterium). Based on the difference of heavy and light isotopes, relative abundance
of protein in the two samples can be acquired. In iTRAQ approach, tagging compound has three
groups: reporter group, balance group, and peptide-reactive group. The peptide-reactive group can
label all free amines at the N terminus and side chain of lysine residues. The total mass of the
9

report group and balance group is always the same while they contain different isotopes in report
ions. Labeled peptides show the same mass in MS scan but release singly charged reporter group
ions of masses 114, 115, 116, or 117 Da during fragmentation. Relative intensities of different
masses of report groups provide relative quantitation. H218O labeling is more convenient and
inexpensive comparing to ICAT and iTRAQ which need specific and expensive reagents. 18O is
labeled into the carboxyl group of peptides during tryptic enzyme digestion. SILAC is a powerful
and relatively simple method for relative quantitation based on MS analysis (Fig. 1). There are two
major phases for SILAC method: adaptation and experiment. In the adaptation phase, two
populations of cells are cultured in two different mediums, one in a medium with light isotope
amino acids (normal) and the other in a medium with heavy isotope amino acids. After a few
passages (usually 5 is enough), most cells in different populations contain different isotope amino
acids and are ready for experiment phase. In the experiment phase, one population of cells will
serve as the experimental group and the other as the control group. Then similar number of cells
from two population are combined and are analyzed together by MS. Heavy isotope-labeled
proteins can be distinguished because of a specific mass shift compare with light isotope-labeled
proteins, for example, a single heavy lysine-containing peptide (13C and

15

N) is heavier than its

light counterpart by 8 Da. Therefore, the ratio of intensities of the peptide pairs can reflect the
relative abundance of peptides or modifications in the peptide between the two conditions of the
cultured cell.
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Figure 1. Stable isotope labeling of amino acids in cell culture
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CHAPTER 2
CHARACTERIZATION OF HISTONE MODIFICATIONS LANDSCAPE CHANGES
DURING THE DIFFERENTIATION OF EMBRYONIC STEM CELLS INTO
CARDIOMYOCYTES

I.

Histone Modifications during Cardiac Differentiation

Histone acetyltransferases (HATs) acetylate lysine residues of histone protein and histone
deacetylase (HDACs) remove the acetylation. Acetylation neutralizes the positive charge on
histone and weakens the interaction between histone and DNA to facilitate the access of
transcription factors. Histone acetylation may also directly serve as the binding site for proteins
involved in gene activation, like the binding of bromodomain factor (Bdf1) is significantly reduced
by mutation of H4 lysine 12 to arginine.28 HDACs have been reported to be important for cardiac
differentiation. HDAC inhibitor trichostatin A (TSA) downregulates HDAC4 activity, activates
myocyte enhancer factors 2 (MEF2), and promotes the cardiac lineage commitment in mouse
ESCs.29
Methylation occurs primarily at lysine and arginine residues in the N-terminal tail of histone
proteins in one of three states: mono-, di-, tri-methylation. Histone methylation controls
transcriptional activity by both activation and repression.20 Methylation of H3K4, H3K36, and
H3K79 have been correlated with gene activation, and di- and tri-methylation at H3K9 and H3K27
have been associate with gene repression.30 Cardiac transcription factor NKX2.5 has a high level
of H3K27me3 in ESCs, which gradually decreases as H3K4me3 and H3K36me3 increased during
12

the cardiac differentiation of ESCs, whereas cardiac structure protein genes show increases in
H3K4me3 and H3K36me3 without H3K27me3.31 Histone methyltransferases (HMTs) mediate the
methylation of histone and histone demethylases (HDMs) catalyze the removal of methyl groups.
HMTs and HDMs can influence cardiac differentiation. Knockdown of disruptor of telomeric
silencing 1-like (DOT1L), histone H3K79 methyltransferase, caused downregulation of NKX2.5
and defect of cardiac differentiation of human embryonic stem cells.32 Jumonji domain-containing
protein D3 (JMJD3), demethylase for H3K27, can interact with insulin gene enhancer binding
protein 1 (ISL1) and regulate cardiac differentiation. Knockout of Jmjd3 impairs expression of
cardiomyocyte markers, α-MHC and β-MHC, and decrease cardiomyocyte differentiation
efficiency of mESCs.33

II.

Materials and Methods

Embryonic stem cell maintenance, storage, and harvest
Mouse embryonic stem cell line, E14, was cultured in a 37°C incubator with humidified
atmosphere of 5% CO2. E14 cells were maintained in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), 1x nonessential amino acids, 2 mM
L-glutamine, 50 U/mL penicillin/streptomycin, 0.12 mM beta-mercaptoethanol (BME) and 103
U/mL leukemia inhibitory factor (LIF). The tissue culture treated plates were coated with 0.2%
gelatin solution in phosphate-buffered saline (PBS). Cells were dissociated with 0.05% trypsin and
passaged at 1:8 ratio every 36 hours.
For storage, cells were dissociated with 0.05% trypsin, washed once with PBS, and
resuspended at 2.5 × 106 cells/mL in freezing media (ES media with 10% Dimethyl sulfoxide
13

(DMSO)) in cryotubes. Cells were frozen in a styrofoam container at -80°C overnight and
transferred into liquid nitrogen for long-term storage. When needed, frozen cells were thawed
rapidly in a 30 °C water bath, mixed with ES media, pelleted to remove DMSO, and resuspended
in mediums media on gelatin-coated dishes. Media were changed in 18 hours and cells were
maintained for 2 passages to fully recover ESC morphology before experiments.
Cells at appropriate confluent were harvested for subsequent experiments. Cells were
dissociated with 0.05% trypsin for 4-5 minutes at 37°C. A maintenance medium was added to stop
trypsinization. Cells were washed once with PBS and pelleted at 6000 g for 5 minutes. The
supernatant was aspirated off and the remaining dry cell pellet was flash-frozen in liquid nitrogen
and then frozen at -80 °C.

Acid-extraction of histone proteins
Harvested 2 × 106 cells were resuspended in in 0.2 mL triton extraction buffer (TEB buffer:
10% PBS and 0.5% triton in water) with 30 mM sodium butyrate, 1 mM phenylmethylsulfonyl
fluoride (PMSF), 1 mM nicotinamide, 1 mM sodium molybdate, 1× Pep, Apro, EtB and leupeptin.
Cells were lysed with microtube pestle, and the nuclei were pelleted at 5000 rpm for 5 minutes at
4°C and washed three times with TEB buffer. Hydrochloric acid (0.2 mL 0.2N) was added into
the tube containing nuclei and rotated for 1 hour at 4°C. The supernatant was transferred into a
new tube after centrifuging at 14,000 rpm at 4°C for 15 minutes and mixed with 50 µL
trichloroacetic acid for 2-hour incubation to precipitate histone proteins. The precipitated histone
proteins were pelleted and washed once with cold acetone after removing supernatant with
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centrifuging at 14,000 rpm at 4°C for 10 minutes. The histone protein pellet was air-dried and
resuspended in autoclaved water.

SDS-PAGE and in-gel digestion
The concentration of acid-extracted histone proteins was determined by Invitrogen Qubit 2.0.
Proteins were mixed with sample buffer, heated at 95°C for 5 minutes to denature before being
loaded onto 18% SDS-PAGE gel and separated with constant current at 0.02 A for about 1 hour
and 40 minutes. Coomassie Blue stain was made with 0.1% Coomassie Brilliant Blue R250, 10%
glacial acetic acid and 50 % methanol, and the de-stain solution was made with 10% glacial acetic
acid, 45% methanol and 45% water. Proteins in the gel were visualized by Coomassie Blue staining
for 1 hour and de-staining overnight.
The gel band that contained histone proteins was cut, diced into small pieces, and placed in a
microcentrifuge tube. Histone H3 protein gel pieces were washed three times with 50 mM Na2CO3
for 10 minutes, treated with freshly made 2% propionic anhydride in 50 mM Na2CO3 four times
for 10 minutes, and then washed three times with 25 mM NH4HCO3 for 15 minutes. All gel pieces
were washed three times with 25 mM NH4HCO3 with 50% acetonitrile (ACN) for 15 minutes and
completely dried in Speed-Vac vacuum concentrator. Various volumes of trypsin solution which
contained 40 ng/mL trypsin in 25 mM NH4HCO3 were added into each tube based on protein
amount. Enough 25 mM NH4HCO3 was added to cover gel pieces and then incubated at 37°C for
2 hours. After a quick spinning, the supernatant was transferred into a new microcentrifuge tube.
Extraction buffer, which contained 2% acetic acid, 50% ACN in HPLC-grade water, was added to
gel pieces and vortexed for 20 minutes. The supernatant was transferred into the new tube. The
15

peptides sample was concentrated with Speed-Vac vacuum concentrator to about 3.5 µL for each
tube and 0.1% formic acid was added to bring up the volume to 7 µL.

Stable isotope labeling of amino acids in cell culture (SILAC)
To prepare heavy isotope-labeled ESCs as the control group, mouse embryonic stem cell, E14
cell line, was cultured in SILAC DMEM supplemented with heavy lysine solution (73 g/mL final
concentration), heavy arginine solution (84 g/mL final concentration), 10% dialyzed FBS, 1x
nonessential amino acids, 2 mM L-glutamine, 50 U/mL penicillin/streptomycin, 0.12 mM betamercaptoethanol (BME) and 103 U/mL leukemia inhibitory factor (LIF). After at least 5 passages,
cells were harvested after counting. Before acid extraction of histone proteins, a similar number of
heavy isotope-labeled ESCs were mixed with light isotope-labeled CMs or ESCs from hydrogel,
followed by acid extraction of histone proteins, SDS-PAGE separation, in-gel digestion, and LCMS analysis of histone modifications.

Cardiomyocytes differentiation - hanging drop method
The differentiation of embryonic stem cells into cardiomyocytes using the hanging drop
method was carried out under similar conditions described previously.34 E14 cells were dissociated
with 0.05% trypsin solution and neutralized with differentiation media, which was DMEM
supplemented with 10% FBS, 1x nonessential amino acids, 2 mM L-glutamine, 50 U/mL
penicillin/streptomycin, and 0.12 mM BME. Cells were centrifuged and resuspended in
differentiation media to a concentration of 2.5 × 104 cells/mL. ES cell-containing media drops
were pipetted on the lid of a 15 cm tissue culture dish (48 hanging drops; 20 µL each drop) with a
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multichannel pipettor. Sterile PBS (15 mL) was added into the dish, leaving cell/media drops on
the lid as hanging drops. After 2 days in the incubator, each cell/media drop was transferred
carefully into one well of a 96-well low attachment plate with 180 µL differentiation media in each
well. After 3 days of culturing, embryoid bodies in each well of the 96-well plate were transferred
into one well of a 48-well gelatin-coated plate with 300 µL differentiation media in each well. Cell
culture media was changed the next day and then every other day.

Cardiomyocytes differentiation - monolayer differentiation method
The monolayer differentiation method was based on an early study by Kokkinopoulos et al. in
2016.35 Mouse embryonic stem cells, E14 cell line, were cultured in ESGRO Complete PLUS
medium (Sigma) supplemented with MEK inhibitor PD-0325901 for two passages. After washing
with PBS, Accutase solution was added to the plate for a 4-minute incubation at 37°C to dissociate
attached cells. Cells were counted and plated onto the 24-well gelatin-coated plate at a density of
1.2 × 105 cells/well for overnight incubation in ESGRO Complete PLUS medium (Sigma)
supplemented with MEK inhibitor PD-0325901. In the morning of the next day, the medium was
changed to serum-free Media, which was made with Iscove's Modified Dulbecco's Medium
(IMDM) and Ham’s F-12 medium (1:1) supplemented with N2 supplement, B27 supplement,
0.05% bovine serum albumin (BSA), L-glutamine, Pen-Strep, 0.5 mM ascorbic acid, and 0.45 mM
monothioglycerol (MTG) for 1 day. The next day, the medium was changed to fresh serum free
medium supplemented with 5 ng/mL Activin A (R&D systems), 5 ng/mL vascular endothelial
growth factor (VEGF, R&D systems), and 0.5 ng/mL bone morphogenetic protein 4 (BMP4, R&D
systems). Two days later, cells were gently washed with PBS and media was changed to StemPro34 SF medium (Gibco) supplemented with 2 mM L-glutamine, 0.5 mM ascorbic acid, 5 ng/mL
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VEGF, 10 ng/mL basic fibroblast growth factor (bFGF, R&D systems) and 50 ng/mL fibroblast
growth factor 10 (FGF10, R&D systems). Media was changed every two days.

Calcium flux
Cells were washed twice with PBS and stained with 4 µM Fluo-8 AM (Abcam) in Dulbecco's
phosphate-buffered saline (DPBS) without calcium for one hour at 37°C. Cells were washed twice
with PBS and then imaged with Nikon A1R laser scanning Confocal Fluorescence Microscope.

Immunofluorescent
Cells were washed twice with PBS before being fixed with 4% paraformaldehyde in PBS for
10 minutes at room temperature. Cells were treated with 0.1% Triton-X 100 in PBS for 15 minutes
at room temperature followed by PBS wash three times. Nonspecific binding sites were preblocked
with 3% BSA in PBS for 30 minutes at room temperature. Cells were incubated with an anticardiac isoform of Troponin T (cTnT, 1:200, mouse monoclonal, Lab Vision) in PBS
supplemented with 1% BSA and 0.05% Triton-X 100 overnight at 4°C. Primary antibody was
aspirated off and cells were treated with donkey anti-mouse secondary antibody (1:1000) in PBS
supplemented with 3% BSA for one hour at room temperature. Cell nuclei were stained with 40
ng/mL 4′,6-diamidino-2-phenylindole (DAPI) for 8 minutes at room temperature on a shaker.
After aspirating off DAPI solution, 0.5 mL PBS was added into each well and samples were ready
for imaging. Images were acquired with Nikon A1R laser scanning Confocal Fluorescence
Microscope.
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Mass Spectrometry Data Analysis
In-gel digestion sample (1 µL) was injected into a Dionex Ultimate 3000 RSLCnano UHPLC
system (Dionex Corporation, Sunnyvale, CA), and separated by a 75-μm × 25-cm PepMap RSLC
column (100 Å, 2 μm) at a flow rate around 450 nL/min. The eluant was connected directly to a
nanoelectrospray ionization source of an LTQ Orbitrap XL mass spectrometer (Thermo Scientific,
Waltham, MA). LC-MS data were acquired in an information-dependent acquisition mode, cycling
between an MS scan (m/z 315-2000) acquired in the Orbitrap, followed by low-energy CID
analysis on the three most intense multiply charged precursors acquired in the linear ion trap.
Histone modifications were identified and quantified using an integrated module in Protein
Prospector, based on a bioinformatic strategy developed in the UCSF Mass Spectrometry Facility.

III.

Results and Discussion

Cardiomyocytes generated from hanging drop method
In order to conduct subsequent experiments, CMs were obtained by carrying out the hanging
drop differentiation method with mouse embryonic stem cells (E14 cell line) and CMs contractions
could be observed around day 7 to 11 after embryoid bodies were transferred into 48-well gelatincoated plate (Fig. 2A and 2B). The synchronized beating of cardiomyocytes requires electrical
coupling of cardiomyocytes through functional gap junction formation. Although the obvious
contracting areas were of various sizes, calcium flux assay using Fluo-8 indicated that about 40%
of the cell population in beating wells were CMs. Table 1 shows percentages of wells that
contained contracting CMs out of total wells in three replicates. The final (day 14) percentages of
wells containing CMs were highly variable from 21% to 76%. There are multiple potential factors
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that contribute to the large variation among replicates. First of all, the hanging drop method relies
on a spontaneous differentiation of ESCs into CMs, which is subject to minor differences in cell
handling during tissue culture. Factors that impact CM differentiation include, but are not limited
to, the starting number of cells in the EBs, medium components, ES cell lines, and the time of EB
plating.36 Secondly, the synchronized beating of CMs requires electrical coupling CMs, which yet
added another layer of variation. To reduce variations in contractile phenotype, we tested small
growth factors and pharmacological reagents guided monolayer CMs differentiation method.

A

B

Figure 2. Contraction of cardiomyocytes by using hanging drop method. (A) and (B) Cells were
shown within the black circle in different time frames. Images were acquired with the Zeiss
Axioplan 2 Imaging upright microscope.
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Table 1: Percentage of wells that contained contracting CMs along the time
Time (day)

6

7

8

9

10

11

12

13

14

Percentage of the

First trial

0

1

1

7

8

20

20

26

37

wells containing

Second trial

0

0

0

0

0

5

5

7

21

contracting CMs (%)

Third trial

0

0

0

6

14

29

44

65

76

Cardiomyocytes generated from monolayer differentiation method
Monolayer differentiation was conducted to get a higher yield of CMs in each well with better
morphology. Contractions were observed around day 20 after ES cells transferring into a gelatincoated 24-well plate (Fig. 3). The beating areas were bigger than CMs generated from the hanging
drop method, likely due to lower efficiency in gap junction formation in the 3D structure of initial
EBs. But longer time (20 days) was needed compared to the original protocol (10-13 days),35 and
the percentage of wells containing CMs was only around 10%.

Figure 3. Contraction of cardiomyocytes by using monolayer differentiation method. Cells are
shown in different time frames to show the contraction.
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Calcium ions flux in cardiomyocytes
CMs have to contract synchronously in a precise order to achieve the function of the heart of
pump blood regulated by a cardiac electrical signal, the action potential (AP).37 AP is orchestrated
by ion currents, including but not limited to the calcium ion (Ca2+) current.38 Increases of
concentration of intracellular Ca2+ during AP activates contraction of cardiomyocytes which
makes Ca2+ as central component of excitation-contraction coupling. Defects of Ca2+ handling and
excitation-contraction coupling are always found in heart failure.39 To characterize the function of
Ca2+ handling, green fluorescent calcium-binding dye, fluo-8 AM (Abcam, Fig. 4A), was used to
report the Ca2+ flux in CMs generated from the monolayer differentiation method (Fig. 4B). From
Fig. 4B, spontaneous Ca2+ flux was observed in approximately 40% of cells in the observed fields,
which suggests the CMs differentiated from ES cells function normally in terms of calcium
handling.

A

B

Figure 4. Calcium flux in cardiomyocytes. (A) Structure of fluo-8 am (CAS number 1345980-406) (B) Cells are shown in different time frames.
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Cardiac troponin T expression in cardiomyocytes
The Ca2+ ions inside myocytes interact with troponin complex to initiate contraction. There are
three subunits in troponin complex: TnC, TnI and TnT.40 TnC is Ca2+-binding subunit and TnT is
a tropomyosin-binding subunit while TnI inhibits the interaction between actin and myosin in the
absence of Ca2+ ions.41 Therefore, the cardiac isoform of troponin T (cTnT) has been used as an
important biomarker for cardiomyocytes. As shown in Fig. 5, cTnT was expressed in CMs
generated from the monolayer differentiation method. Similar to calcium flux assay, about 30% of
cells in the observed field stained positive for cTnT.

Figure 5. Immunostaining of cardiac troponin T. Cell nuclei were stained with DAPI (blue).
Cardiac troponin T (cTnT) was targeted with mouse anti-cTnT antibody and revealed with donkey
anti-mouse IgG (Alexa Fluor, red).

Histone modifications in cardiomyocytes
Histone proteins were extracted from cells containing the same amount of CMs and heavy
isotope-labeled ES cells and separated by SDS-PAGE (Fig. 6A). H3, H4, H2A, and H2B bands
were cut, transferred into clean microcentrifuge tubes, and in-gel digested before being analyzed
through LC-MS. Nearly all reported modifications in histone protein H3 and H4 were identified
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by MS analysis (Fig. 6B), including but not limited to H3K27ac, H3K27me, H3K27me3,
H3K36me, and H3K79me, which play important role in cardiac differentiation.

A

B

Figure 6. Histone modifications identified in ES cells. (A) SDS-PAGE of purified histone proteins;
(B) Histone modifications identified in ES cells by mass spectrometry.

Histone modifications were not only identified, but also quantified by MS analysis (Fig. 7).
The heavy isotope-labeled peptides in ES cells will show a mass shift in MS data comparing to
light isotope-labeled peptides in CMs. Based on this mass separation, post-translationally modified
peptides could be quantified to help understand the changes in histone epigenetic state during ES
cells differentiation into CMs. As shown in Fig. 7A, H4 peptide containing K12 and K16
acetylation was increased in CMs comparing to ES cells (PSCs, Fig. 7A, Left panel). But H4
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peptide containing acetylated K12 and unmodified K16 was decreased in CMs (Fig. 7A, Middle
panel). Meanwhile, levels of a tryptic peptide from the unmodified region of H4 remained similar
in CMs and ES cells, consistent with equal mixing of CM and ES cells (Fig. 7A, Right panel).
Therefore, our data suggested that H4K16ac was upregulated in CMs. In addition, most b ions and
y ions were shown in the MSMS spectra of these modified peptides for conclusive, site-specific
assignment of the peptide sequence, as well as the nature and site of modifications. A
representative MSMS spectrum is included in Fig. 7B to show the high confidence identification
of modified peptides. Histone H4 K5acK8acK12acK16ac, K8acK12acK16ac, and K12acK16ac
peptides were all increased in CM compared to ES cells; while corresponding peptides with
unmodified K16, such as K5acK8acK12ac, K8acK12ac, and K12ac peptides, were decreased in
CM compared to ES cells (Fig. 7C). To remove the impact of acetylation level changes on other
residues, the light/heavy ratio of these K16 unmodified peptides (K5acK8acK12ac, K8acK12ac,
and K12ac) was used to normalize the light/heavy ratio of corresponding K16 acetylated peptides
(K5acK8acK12acK16ac, K8acK12acK16ac, and K12acK16ac), as illustrated in the following
formula (P+K16ac: peptide containing K16ac and other specific modifications; P-K16ac:
corresponding peptide containing other specific modifications without K16ac):

Normalized Ratio =

𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑷(+𝑲𝟏𝟔𝒂𝒄) 𝑖𝑛 𝐶𝑀𝑠 𝑡𝑜 𝐸𝑆 𝑐𝑒𝑙𝑙𝑠
𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑷(-𝑲𝟏𝟔𝒂𝒄) 𝑖𝑛 𝐶𝑀𝑠 𝑡𝑜 𝐸𝑆 𝑐𝑒𝑙𝑙𝑠

After ratio normalizing to remove the effects of acetylation level on other residues, it becomes
obvious K16ac were upregulated with statistical significance in histone H4 isoforms regardless of
the acetylation state of K5, K8 and K12 residues in CM compared to ES cells (Fig. 7D). H4K16ac
is a universal and reversible posttranslational modification which suggests that a single histone
modification can have multiple effects on chromatin structure. H4K16ac weakens the self25

association of nucleosome core particles42 and contributes to decondensed chromatin in eukaryotic
organisms by inhibiting the ATP-dependent chromatin assembly.43 A high level of H4K16ac
around transcription start sites of active genes was found in ES cells44 and H4K16ac was
downregulated during ES cell differentiation into embryonic fibroblasts.45 Here, the data shows
that acetylation of H4K16ac plays an important role in cardiomyocytes differentiation, and
enriched H4K16ac may promote CM differentiation.
Among histone 3 modifications, acetylation and dimethylation or trimethylation of K4
(H3K4me2 or H3K4me3) are commonly associated with active transcription. Methylation of
H3K9 is constitutive heterochromatin mark.46 In CMs comparing to ESCs, there is a significant
decrease in active transcription marks, H3K4me, H3K9ac, and H3K14ac; and constitutive
heterochromatin marks, H3K9me is significant decreased while H3K9me3 is upregulated. Histone
3 variant H3.3 K27me2 and K36me are significantly decreased (Fig. 7E).
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A

C

B

D

E

Figure 7. Histone modifications changes in CM differentiation. (A) An increase in H4 peptide
containing K12 and K16 acetylation was found by MS spectra (Left) in CM (orange) while a
decrease in H4 peptide containing only K12 acetylation (Middle) and a similar amount of total
peptides (Right); (B) H4 peptide with K12 and K16 acetylation was identified by MSMS spectrum;
(C) The ratio of H4 peptides containing different modification combinations in CMs to ES cells;
(D) The ratio of H4 peptides containing K16 acetylation in CMs to ES cells normalized by H4
peptides without K16 acetylation. (E) The ratio of H3 modifications in CMs to ES cells. ** p <
0.01, *** p < 0.001 (Student’s t-test).
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IV.

Conclusion

Cardiomyocytes were differentiated from mouse embryonic stem cells, with normal calcium
handling function and cardiac troponin T expression. During cardiomyocyte differentiation,
histone H4 lysine 16 acetylation was significantly down-regulated; histone H3 active transcription
marks, H3K4me, H3K9ac, and H3K14ac, were down-regulated, and heterochromatin mark,
H3K9me3, was up-regulated. This work suggests that H4K16ac plays an important role in
cardiomyocyte differentiation.
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CHAPTER 3
CHARACTERIZATION OF INFLUENCE OF HYDROGEL CULTURING IN HISTONE
MODIFICATIONS LANDSCAPE

I.

Mechanosensing

Mechanosensing is the process that a cell senses the mechanical force of its microenvironment
and makes responses including proliferation or apoptosis, activation or inactivation and
differentiation or not. Mechanosensing involves the function of cellular macromolecular
assemblies, including mechanosensitive ion channels on the plasma membrane, the primary
cilium, integrin-mediated cell-matrix adhesions, cadherin-mediated cell-cell adhesions, the
actomyosin cytoskeleton, the nucleoskeleton,

Notch and growth

factor receptors.47

Phosphorylation is one of the immediate responses of cells to mechanical stimulus, which was
reported to regulate the activity and localization of proteins in Mechanosensing process. In both
zebrafish and Drosophila embryos, early mesoderm differentiation is mechanically induced by the
movement of embryogenesis. This mechanical strain opens the interaction between Y654 βcatenin and D665 E-cadherin, and triggers phosphorylation of β-catenin Y654 by Src-family
kinase. The phosphorylation of β-catenin Y654 decreases the affinity of E-cadherin to β-catenin
and releases β-catenin from the junctions into cytoplasm and later to the nucleus, where it triggers
mesoderm

transcription-factor

expression

during

gastrulation.48

The

importance

of

phosphorylation signal is recognized, but phosphorylation change and related signaling pathways
in mechanosensing process still need to be elucidated.
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The mechanosensing also influences cell epigenetic state by controlling nuclear pores and
chromatin structure. During Hippo signaling pathway, large tumor suppressor (LATS)
phosphorylate transcription coactivators YAP/TAZ to keep them in cytoplasm, whereas nonphosphorylated YAP/TAZ accumulate in nucleus. But the nuclear deformation by atomic force
microscopy was shown increasing nuclear import of transcription factor YAP/TAZ independent
of the Hippo signaling pathway, which suggested that opening or closing nuclear pores play a role
in transcription regulation during mechanosensing.49 By altering cell geometry, cytoplasmic-tonuclear redistribution of histone deacetylase 3 (HDAC3) and decreased histone H3K9ac was
found, accompanied by reduced actomyosin contractility.50 It was proposed that by inhibiting
actomyosin contractility, the inhibitor Bα (IB-α), which is associated with HDAC3 in
cytoplasm, degrades and releases HDAC3 to nuclear. But the pathways between mechanosensing
and histone modifications remain elusive.

II.

Materials and Methods

Embryonic Stem Cells Culturing
For conventional 2D culture, mouse embryonic stem cell line E14 was plated on tissue culturetreated dishes coated with 0.2% gelatin solution in phosphate buffered saline (PBS). The incubator
for tissue culture was set at 37°C with 5% CO2. E14 cells were maintained in ES medium
containing Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 1x nonessential amino acids, 2 mM L-glutamine, 50 U/mL penicillin/streptomycin,
0.12 mM beta-mercaptoethanol (BME), and 103 U/mL leukemia inhibitory factor (LIF). Cells at
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appropriate confluence were detached with 0.05% trypsin solution and resuspended in ES medium
at a density of 2.5 × 106 cells/mL for seeding.
The gelatin microporous hydrogel was prepared by the water-in-oil emulsion method.51 For
3D hydrogel culture, 0.05 g per well-sterilized hydrogel was placed in a 24-well plate before
mixing with 350 µL ES medium. After 15 minutes of incubation at room temperature, 1 × 106 cells
in 150 µL cell suspension was added into each well and mixed well with the hydrogel. Filtersterilized microbial transglutaminase (mTG) solution at 20% (w/v) concentration in PBS was
added (100 µL for each well of a 24-well dish) before incubating at 37°C for 30 minutes.51 Each
cured cell-containing hydrogel block prepared from a 24-well dish was then transferred into one
well of a 6-well plate and cultured in 5 mL ES medium per well with media changed every day.
To release encapsulated cells, the hydrogel was diced in small pieces after washing carefully
with PBS twice. Freshly made collagenase from Clostridium histolyticum (Sigma), 4 mg
suspended in 4 mL sterile PBS, was added into each well and mixed well with hydrogel. The plate
was shaken every 10 minutes for a 30-minute incubation at 37°C. Collagenase was quenched with
ES media and aspirated off after pelleting the cells. Cells were dissociated with 0.05% trypsin
solution and resuspended in ES media. Cells were washed twice with PBS (pH 7.4) and pelleted
at 6000 g for 5 minutes. After aspirating off supernatant, cells were flash-frozen in liquid nitrogen
and stored at -80 °C before subsequent experiments.

CMs differentiation by hanging drop method starting with ESCs released from hydrogel
E14 cells at appropriate confluence were dissociated with 0.05% trypsin and neutralized with
ES media. Cells were divided into two portions. The first portion of cells served as differentiation
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with normal ESCs from the tissue culture plate (2D culture system). Cells were washed once with
PBS and resuspended in differentiation media for further hanging drop differentiation.
The second population of cells went into the differentiation process after 48-hour culturing in
the hydrogel. Cells were counted with a hemocytometer counter and diluted with ES media to a
concentration of 2.5 × 106 cells/mL. Sterilized gelatin microgel was placed in a 24-well plate (0.05
g per well) before mixing with 300 µL ES media. After 15 minutes of incubation at room
temperature, 200 µL cell suspension, 5 × 105 cells were added into each well and mixed well with
the hydrogel. Filter sterilized microbial transglutaminase (mTG) solution at 20% (w/v)
concentration in PBS was added into each well (100 µL mTG) followed by 37°C incubation for
30 minutes. Each block of cell-encapsulating hydrogel from a 24-well dish was transferred into
one well of a 6-well plate. Cells were cultured in 5 mL ES media per well for 48 hours and media
was changed every day. After 48 hours, cells were released with collagenase from Clostridium
histolyticum (Sigma) solution and dissociated with 0.05% trypsin solution. Then, cells were
washed once with PBS and resuspended in differentiation media for hanging drop differentiation.
For hanging drop differentiation, cells were counted and diluted to a concentration of 2.5 × 104
cells/mL. ES cell-containing media drops were pipetted on the lid of a 15 cm tissue culture dish
(48 hanging drops; 20 µL each drop) with a multichannel pipettor. Sterile PBS (15 mL) was added
into the dish to maintain the humidity in the dish, leaving cell/media drops on the lid as hanging
drops. After 2 days in the incubator with a humidified atmosphere of 5% CO2 at 37°C, cell/media
drop was transferred carefully into one well of a 96-well low attachment plate with 180 µL
differentiation medium in each well. After 3 days of culturing, embryoid bodies in each well of
the 96-well plate were transferred into one well of a 48-well gelatin-coated plate with 300 µL
differentiation medium in each well. Media was changed the next day and then every other day.
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The plates were checked every day under the microscope for 14 days and the number of wells
containing contractile CMs was recorded.
Acid-extraction of histone proteins
Harvested 2 × 106 cells were resuspended in in 0.2 mL triton extraction buffer (TEB buffer:
10% PBS and 0.5% triton in water) with 30 mM sodium butyrate, 1 mM phenylmethylsulfonyl
fluoride (PMSF), 1 mM nicotinamide, 1 mM sodium molybdate, 1× Pep, Apro, EtB and leupeptin.
Cells were lysed with microtube pestle. The nuclei were pelleted at 5000 rpm for 5 minutes at 4°C,
and the supernatant including cytoplasmic extract was transferred to a clean tube and saved for
phosphoproteomics analysis. The nuclei were washed three times with TEB buffer. Hydrochloric
acid (0.2 mL 0.2N) was added into the tube containing nuclei and rotated for 1 hour at 4°C. The
supernatant was transferred into a new tube after centrifuging at 14,000 rpm at 4°C for 15 minutes
and mixed with 50 µL trichloroacetic acid for 2-hour incubation to precipitate histone proteins.
The precipitated histone proteins were pelleted and washed once with cold acetone after removing
supernatant with centrifuging at 14,000 rpm at 4°C for 10 minutes. Histone protein pellet was airdried and resuspended in autoclaved water.

SDS-PAGE and in-gel digestion
The concentration of acid-extracted histone proteins or cytoplasmic extract was determined by
Invitrogen Qubit 2.0. Proteins were mixed with sample buffer, heated at 95°C for 5 minutes to
denature before being loaded onto 18% SDS-PAGE gel and separated with constant current at
0.02A. Coomassie Blue stain was made with 0.1% Coomassie Brilliant Blue R250, 10% glacial
acetic acid and 50 % methanol, and de-stain solution was made with 10% glacial acetic acid, 45%
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methanol and 45% water. Proteins in the gel were visualized by Coomassie Blue staining for 1
hour and de-staining overnight.
The gel band that contained histone proteins or cytoplasmic extract was cut, diced into small
pieces, and placed in a microcentrifuge tube. For histone protein bands, histone H3 protein gel
pieces were washed three times with 50 mM Na2CO3 for 10 minutes, treated with freshly made 2%
propionic anhydride in 50 mM Na2CO3 four times for 10 minutes and then washed three times
with 25 mM NH4HCO3 for 15 minutes. All histone protein gel pieces were washed three times
with 25 mM NH4HCO3 with 50% acetonitrile (ACN) for 15 minutes and completely dried in a
Speed-Vac vacuum concentrator. For cytoplasmic extract gel bands, gel pieces were washed three
times with 25 mM NH4HCO3 with 50% ACN for 15 minutes, treated with 10 mM dithiothreitol in
25 mM NH4HCO3 at 56ºC for 1 hour and 55mM iodoacetamide in 25 mM NH4HCO3 in the dark
for 45 minutes. All gel pieces were washed two times with 25 mM NH4HCO3 for 10 minutes, three
times with 25 mM NH4HCO3 with 50% ACN for 15 minutes and completely dried in a Speed-Vac
vacuum concentrator.
Various volumes of trypsin solution which contained 40 ng/mL trypsin in 25 mM NH4HCO3
were added into each tube based on protein amount. Enough 25 mM NH4HCO3 was added to cover
gel pieces and then incubated at 37°C for 2 hours. After a quick spinning, the supernatant was
transferred into a new microcentrifuge tube. Extraction buffer, which contained 2% acetic acid,
50% ACN in HPLC-grade water, was added to gel pieces and vortexed for 20 minutes. The
supernatant was transferred into the new tube. The peptides sample was concentrated with SpeedVac vacuum concentrator to about 3.5 µL for each tube and 0.1% formic acid was added to bring
up the volume to 7 µL.
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Stable isotope labeling of amino acids in cell culture (SILAC)
To prepare heavy isotope-labeled ESCs as the control group, mouse embryonic stem cell, E14
cell line, was cultured in SILAC DMEM supplemented with heavy lysine solution (73 g/mL final
concentration), heavy arginine solution (84 g/mL final concentration), 10% dialyzed FBS, 1x
nonessential amino acids, 2 mM L-glutamine, 50 U/mL penicillin/streptomycin, 0.12 mM betamercaptoethanol (BME) and 103 U/mL leukemia inhibitory factor (LIF). After at least 5 passages,
cells were harvested after counting. Before acid extraction of histone proteins, a similar number of
heavy isotope-labeled ESCs were mixed with light isotope-labeled CMs or ESCs from hydrogel,
followed by acid extraction of histone proteins, SDS-PAGE separation, in-gel digestion, and LCMS analysis of histone modifications.

Quantitative Phosphoproteomics analysis
Phosphopeptides were enriched by Titansphere Phos-TiO Tip (GL Sciences Inc.) The
Titansphere Phos-TiO Tip was washed with 20 µl buffer A (80% ACN and 0.4% trifluoroacetic
acid) and 20 µl buffer B (25% lactose acid, 60% ACN, and 0.3% trifluoroacetic). In-gel digested
cytoplasmic extract sample was mixed with 100 µl buffer B and then loaded onto Titansphere
Phos-TiO Tip. The tip column was washed with 20 µl buffer B and 20 µl buffer A. The
phosphopeptides were eluted with 50 µl 5% ammonium hydroxide followed by 50 µl 5%
pyrrolidine. Enriched phosphopeptides were concentrated with a Speed-Vac vacuum concentrator
for mass spectrometric analysis.
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Phosphorylation of different proteins was identified and quantified using an integrated module
in Protein Prospector, based on a bioinformatic strategy developed in the UCSF Mass
Spectrometry Facility. Further data processing was done using Perseus (v. 1.5.0.0) and PHOTON52.

Cells Viability in Hydrogel
The working solution was made with Live Dead Cell Viability Assay Kit (Sigma) in DPBS.
Hydrogel with encapsulated cells was transferred into a new 6-well plate and 5 mL working
solution was added into each well for a 30-minute incubation at 37 °C. Images were acquired with
Nikon A1R laser scanning Confocal Fluorescence Microscope. Cells were kept in dark during all
operations.
To test cell viability after releasing from hydrogel, 50 µL 0.4% trypan blue dye was added into
50 µL cell suspension and mixed with pipette. Cells were counted in hemocytometer counter.

Mass Spectrometry Data Analysis
1 µL of in-gel digestion sample was injected into a Dionex Ultimate 3000 RSLCnano UHPLC
system (Dionex Corporation, Sunnyvale, CA), and separated by a 75-μm × 25-cm PepMap RSLC
column (100 Å, 2 μm) at a flow rate of ~ 450 nL/min. The eluant was connected directly to a
nanoelectrospray ionization source of an LTQ Orbitrap XL mass spectrometer (Thermo Scientific,
Waltham, MA). LC-MS data were acquired in an information-dependent acquisition mode, cycling
between an MS scan (m/z 315-2000) acquired in the Orbitrap, followed by low-energy CID
analysis on the three most intense multiply charged precursors acquired in the linear ion trap.
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Histone modifications were identified and quantified using an integrated module in Protein
Prospector, based on a bioinformatic strategy developed in the UCSF Mass Spectrometry Facility.

III.

Results and Discussion

Cell viability in hydrogel culturing
In order to test if ESCs were able to proliferate normally in hydrogel culturing, cell viability
tests were conducted. First, Live Dead Cell Viability Assay was carried out at 1 hour and 24 hours
after encapsulating ESCs in hydrogel (Fig. 8A). Viable cells were stained in green while dead cells
were stained in red. As shown in Fig. 8A, after encapsulation in hydrogel for 1 hour, most cells
were viable (green) with a small number of dead cells (red) with cell membrane compromised
during cell handling procedures. At growing in hydrogel for 24 hours, live small colonies could be
visualized in Live Dead Cell Viability Assay with a few dead cells, suggesting normal proliferation
of ESCs in hydrogel. The impacts of hydrogel encapsulation on ESC self-renewal and pluripotency
were then assessed after ESCs cultured in hydrogel for 48 hours. After being released from
hydrogel, the viability of ESCs was assessed with trypan blue. Only a negligible amount of dead
cells were detected after hydrogel encapsulation and collagenase release, similar to the number of
dead cells detected after normal passage from conventional 2D tissue culture plates (Fig. 8B).
Furthermore, after being released from hydrogel, ESCs were seeded back into a new gelatin-coated
conventional tissue culture plate with ES media to show if hydrogel culture would alternate the
pluripotency of E14 cells. After incubation at 37°C with a humidified atmosphere of 5% CO2
overnight, cells were attached to the plate and formed small colonies with the same cell
morphology like ESCs directly passaged from another 2D plate with similar incubation time (Fig.
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8C). Overall, we conclude that the hydrogel encapsulation and culture are suitable for mouse ESCs,
and that ESCs maintain their normal pluripotency even after 48 hours of culturing in hydrogel. In
addition, collagenase facilitated the release of the ESCs encapsulated in hydrogel won’t change
the status of ESCs and provides the opportunity for utilization of ESCs for further experiments and
analysis.

B

A

C

Figure 8. Cell viability results in hydrogel culturing. (A) Live/dead assay results of ESCs culturing
in hydrogel after 1 hour (left) and 24 hours (right) trapping in hydrogel; (B) Viable cells
percentages comparison between releasing from hydrogel culturing and dissociating from normal
tissue culture (TC) plate culturing; (C) The morphology of ESCs released from hydrogel (left) and
normal TC plate (right).
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Histone modifications changes in hydrogel culturing
After 48-hour culturing in hydrogel, ESCs were released, harvested, and mixed with same
amount of heavy isotope-labeled ESCs that were harvested from conventional tissue culture plate.
Histone proteins were extracted from the combined population of cells and ran through mass
spectrometry. Quantitative mass spectrometric analysis was carried out based on the mass shift of
heavy isotope-labeled peptides from ESCs in tissue culture plate compared to normal peptides
from ESCs in hydrogel. For histone H3 modifications, there was a significant decrease in active
transcription marks, H3K4me, H3K14ac, H3K18ac, and H3K36me, but H3K27me3, a highly
reversible gene-repressive mark, was significantly increased in ESCs released from hydrogel
comparing to ESCs from normal tissue culture plate (Fig. 9A). For histone H4 modifications, an
overall increase in peptides containing K16ac was found after hydrogel culturing, including
K5acK8acK12acK16ac, K8acK12acK16acK, and K12acK16ac. Corresponding peptides without
K16ac, including K5acK8acK12ac, K8acK12ac, and K12ac, were decreased after hydrogel
culturing comparing to normal ESCs from tissue culturing plate (Fig. 9B). To demonstrate the
pattern more clearly, the light/heavy ratios of peptides containing K16ac from hydrogel to normal
ESCs were normalized with the light/heavy ratio of corresponding K16 unmodified peptide ratios
using the following formula (P+K16ac: peptide containing K16ac and other specific modifications;
P-K16ac: corresponding peptide containing other specific modifications without K16ac):

Normalized Ratio =

𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑷(+𝑲𝟏𝟔𝒂𝒄) 𝑖𝑛 ℎ𝑦𝑑𝑟𝑜𝑔𝑒𝑙 𝑡𝑜 𝑛𝑜𝑟𝑚𝑎𝑙 𝐸𝑆𝐶𝑠
𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑷(-𝑲𝟏𝟔𝒂𝒄) 𝑖𝑛 ℎ𝑦𝑑𝑟𝑜𝑔𝑒𝑙 𝑡𝑜 𝑛𝑜𝑟𝑚𝑎𝑙 𝐸𝑆𝐶𝑠

The normalized ratios of K16ac peptides were all higher than 1 which suggests that K16ac is
significant increased after 48-hour culturing in hydrogel.

39

A

C

B

Figure 9. Histone modifications changes in hydrogel culturing. (A) Ratios of histone 3
modifications in hydrogel to TC plate; (B) The ratios of H4 peptides containing different
modification combinations in hydrogel to TC plate; (C) The ratio of H4 peptides containing K16
acetylation in hydrogel to TC plate normalized by H4 peptides without K16 acetylation. * p < 0.05,
** p < 0.01, *** p < 0.001 (Student’s t-test).
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Phosphoproteomics analysis in hydrogel culturing
Cytoplasmic extract was saved during the extraction of histone proteins and phosphopeptides
were enriched by Titansphere Phos-TiO Tip for quantitative mass spectrometric analysis. The
result showed that phosphorylation of glycogen synthase kinase-3 alpha (Gsk3a), catenin alpha-1
(Ctnna1), and catenin beta-1 (Ctnnb1) were all decreased in ESCs after 48-hour culturing in
hydrogel compare to ESCs in tissue culture plate, and the interaction network between these
proteins is shown in Fig. 10A. GSK3a was activated through phosphorylation of tyrosine 279
(Y279), and it phosphorylates the N-terminal domain of β-catenin to target it for degradation
process.53 As described previously, cardiomyocyte lineage specification required an early Wnt/βcatenin signaling activation and a later Wnt/β-catenin signaling inhibition. After hydrogel
culturing, the low phosphorylation level of GSK3a, accompanied with a low phosphorylation level
of β-catenin, suggested that β-catenin might accumulate in the cytoplasm, activate Wnt/β-catenin
signaling and therefore, promote CM differentiation. HDAC1 and HDAC2 phosphorylation were
also decreased after hydrogel culturing in our data. The phosphorylation of HDAC1 and HDAC2
might increase their affinity for interacting proteins54, including transcriptional corepressor
Sin3a17, thereby increase the activity of HDAC1 and HDAC2. The lower phosphorylation level of
HDAC1 and HDAC2 implies that histone acetylation might be upregulated, like H4K16ac, in
ESCs responding to mechanical stimulus in hydrogel.
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A

B

Figure 10. Protein-protein interaction network about (A) Gsk3a, Ctnna1 and Ctnnb1; (B) HDAC1
and HDAC2.

Cardiomyocytes differentiation after hydrogel culturing
In order to investigate the effects of hydrogel encapsulation in CMs differentiation, ESCs were
differentiated into CMs through the hanging drop differentiation method after 48 hours of hydrogel
encapsulation. Table 2 shows the comparison of the cumulative number of wells containing
contractile CMs along a 14-day period between hydrogel-released ESCs and normal ESCs in three
trials. The data suggests that hydrogel encapsulation promotes the differentiation of ESCs into
CMs by shifting the emergence of contractile CMs earlier for 1-3 days (Table 2). Several studies
have reported the influence of the three-dimensional (3D) cell culture system in ESCs
differentiation.55, 56 And the 3D culture system was found to promote CM differentiation.57, 58 But
little is known about the underlying molecular mechanisms, especially from the epigenetic point
of view. Our study revealed that histone H4K16ac was significantly upregulated both in CMs and
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ESCs released from hydrogel comparing to normal ESCs (Fig. 7D and Fig. 9C). Therefore, our
results suggested that the upregulation of H4K16ac in hydrogel encapsulation primes the ESCs to
overcome the epigenetic barrier and facilitate ESC to differentiate into functional CMs.
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Table 2: Cumulative number of wells containing contractile CMs starting with ESCs releasing from hydrogel comparing to ESCs from
2D culturing system along the time

Time (day)

0

4

5

6

7

8

9

10

11

12

13

14

2D

0

0

0

0

0.5

0.5

4

5

12

12

15.5 22

Number

hydrogel

0

3

5

6

6

6

6

6

8

15

15

18

of wells

2D

0

0

0

0

0

0

0

0

2

2

3

9

containing

hydrogel

0

0

0

0

0

1

1

4

6

16

19

25

CMs

2D

0

0

0

0

0

0

4

9

18

28

41

48

hydrogel

0

0

0

0

0

2

5

7

19

22

28

33

First trial

Second trial
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Third trial

IV.

Conclusion

Microporous hydrogel is suitable for mouse embryonic stem cell culture, without a noticeable
impact on cell proliferation and pluripotency. Hydrogel encapsulation promotes the differentiation
of embryonic stem cells into cardiomyocytes at the early stage. Similar to cardiomyocyte
differentiation, after culturing in hydrogel, an overall decrease in transcription marks and an
increase in heterochromatin mark on histone H3 were observed, accompanied by a significant
increase of H4K16ac. Phosphoproteomics analysis reveals that hydrogel culture regulates
chromatin structure through HDACs, and turned on Wnt signaling pathway for the early stage of
cardiomyocyte differentiation.
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CHAPTER 4
CONCLUSION AND FUTURE DIRECTIONS
The first aim of this project was to characterize histone modifications changes during ESC
differentiation into CM. Histone modifications were identified and quantified with LC-MS/MS.
Two different methods of differentiation, hanging drop and monolayer, were carried out to induce
ESCs differentiation into CMs and both were able to generate contractile CMs. To demonstrate
the cardiac contractile function of differentiated CMs, calcium flux and cTnT expression in mouse
ESC-derived CMs were imaged with the florescence confocal microscope. Both assays confirmed
a highly enriched cell population with CM lineage. MS results indicated a significant decrease in
active transcription marks, H3K4me, H3K9ac and H3K14ac in CMs comparing to ESCs. H4K16ac
was significantly upregulated during the differentiation which suggests that H4K16ac may
promote the CM differentiation.
The second aim was to characterize the effects of hydrogel encapsulation on histone epigenetic
state. ESCs were trapped in gelatin macroporous hydrogel for 2 days of culturing and cell viability
test results indicated that cells proliferated normally as in the normal tissue culture plate. ESCs in
hydrogel were also released from hydrogel for further analysis without any noticeable impacts on
cell viability or ESC pluripotency. After being assured that hydrogel encapsulation does not impact
ESCs, ESCs were encapsulated in hydrogel for 48 hours then differentiated into CMs using the
hanging drop differentiation method. A significant expedition was observed in CM differentiation
when compared to ESCs from conventional tissue culture plates. To understand the impacts of
hydrogel encapsulation on ESC histone epigenetic state, histone proteins were extracted from
ESCs released from hydrogel and analyzed with LC-MS/MS. Results showed that active
46

transcription marks, H3K4me, H3K9ac, and H3K79me were significant decreased while H4K16ac
increased significantly after culturing in hydrogel. With a similar increase of H4K16ac in CM
differentiation, it is likely hydrogel encapsulation facilitates ESC to overcome the epigenetic
barrier related to histone H4K16ac and promote ESC differentiation into the cardiomyocyte.
Moving forward, there are still many knowledge gaps this project can help fill in. For the
differentiation method, high variation and low yield of the hanging drop method make it not
suitable for acquiring pure and good amount of CMs. To optimize the monolayer differentiation
method, titration of growth factors may be helpful to improve efficiency and find optimal protocol.
Flowcytometry is one option to filter out non-CM cells and quantify the CMs by staining CM
markers like cTnT. With a higher proportion of CMs in the sample, the MS data will be more
accurate and consistent, and the pattern may be clearer. On the other hand, the parameter of
hydrogel can also be investigated to find more factors that influence the CM differentiation, like
the size of pores and stiffness. To validate the enrichment of H4K16ac in CMs, cells can be treated
with H4K16ac antibody and cTnT antibody together to see if the signals are colocalized or not.
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